CIK 0001837607 · <br>Emerging growth company
AEON Biopharma, Inc.
Sign in to watch- Ticker
- AEON
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 853940478
- Phone
- (949) 354-6499
- Business address
- 130 VANTIS DRIVE, SUITE 170, ALISO VIEJO, CA, 92656
- Former names
- Priveterra Acquisition Corp.
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Regulation FD disclosure
- 10-K Report Annual Report
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Regulation FD disclosure
- 8-K Event Shareholder rights changed · Bylaws or fiscal year change · Shareholder vote results
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-4/A Deal Registration Statement - Business Combination
- DEFA14A Proxy Proxy Materials
- 8-K Event Other events
- UPLOAD Other SEC-generated Letter
- UPLOAD Other SEC-generated Letter
- DEFA14A Proxy Proxy Materials
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Material agreement
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Regulation FD disclosure
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Regulation FD disclosure
- S-4 Deal Registration Statement - Business Combination
Page 16 of 19 · 363 filings